taest16001
Cell therapyexperimental
Clinical trial activity
2 trials · 6 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Jun 1, 2017 (NCT03159585)
Timeline
2010s
- Jan 1, 2017
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- Cancer/testis antigen 1Immunity, passive
Cancer/testis antigen 1 immunity, passive
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- taest16001
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT04318964 | Phase 1 | Mar 20, 2020 | Guangdong Xiangxue Precision Medical Technology Co., Ltd., Sun Yat-Sen University |
| NCT03159585 | Phase 1 | Jun 1, 2017 | Guangdong Xiangxue Precision Medical Technology Co., Ltd, Guangzhou Xiangxue Pharmaceutical Co., Ltd, Southern Medical University, Xiangxue Life Science Research Center |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (6)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Guangdong Xiangxue Precision Medical Technology Co., Ltd | For profit | 1 | 0 | 1 | 2017 |
| Guangdong Xiangxue Precision Medical Technology Co., Ltd. | Academic/Hospital | 1 | 0 | 1 | 2020 |
| Guangzhou Xiangxue Pharmaceutical Co., Ltd | For profit | 1 | 0 | 1 | 2017 |
| Southern Medical University | Academic/Hospital | 1 | 1 | 1 | 2017 |
| Sun Yat-Sen University | Academic/Hospital | 1 | 1 | 1 | 2020 |
| Xiangxue Life Science Research Center | Academic/Hospital | 1 | 0 | 1 | 2017 |
6 organizations
Page 1 / 1